登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000972 证券简称：*ST中基 公告编号：2025-096号 中基健康产业股份有限公司 第十届董事会第十八次临时会议 决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 中基健康产业股份有限公司（以下简称"公司"）第十届董事会第十八次临时会议于2025年12月5日（星 期五）以传真通讯方式召开，本次会议于2025年12月1日以电子邮件方式发出会议通知。在确保公司全 体董事充分了解会议内容的基础上，公司9名董事在规定的时间内参加了表决。会议的召开符合《公司 法》和《公司章程》的有关规定。会议审议并一致通过了如下决议： 1、审议通过《关于全资子公司红色番茄拟向股东方六师国资公司借款展期暨关联交易的议案》； 表决结果：同意8票；反对0票；弃权0票。 关联董事袁家东先生回避表决，详见公司于同日披露的《关于全资子公司红色番茄拟向股东方六师国资 公司借款展期暨关联交易的公告》。 2、审议通过《关于子公司获得债务豁免暨关联交易的议案》； 表决结果：同意7票；反对0票；弃权0票。 关联董事袁家东先生、李娟女士 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001896 证券简称：豫能控股 公告编号：临2025-65 河南豫能控股股份有限公司 第九届董事会第三十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 1.河南豫能控股股份有限公司（以下简称"公司"）第九届董事会第三十一次会议召开通知于2025年12月 2日以书面形式发出。 2.2025年12月5日，会议在郑州市农业路东41号投资大厦A座2507会议室以现场结合通讯表决方式召开。 3.本次会议应出席会议董事7人，董事长余德忠，董事李军、王璞、贾伟东和独立董事史建庄、叶建 华、赵剑英共7人出席了会议，其中董事李军、王璞，独立董事史建庄、赵剑英通过通讯表决方式参 加。 （一）审议通过了《关于调整2025年度日常关联交易预计的议案》 4.本次会议由董事长余德忠主持。列席本次会议的有：公司总会计师王萍，董事会秘书李琳，证券事务 代表魏强龙。 5.会议的召集、召开和出席会议人数均符合《中华人民共和国公司法》等有关法律、行政法规、部门规 章、规范性文件和《公司章程》的规 ...

中经记者 李哲 北京报道 兖矿能源（600188.SH、01171.HK）再度筹划与控股股东山东能源集团有限公司（以下简称"山能集 团"）进行关联交易。 近日，兖矿能源公告披露，其全资附属公司拟以约3.45亿元收购山东能源装备集团高端支架制造有限公 司（以下简称"高端支架公司"）100%股权。 由于高端支架公司的全资持股方山东能源集团重型装备制造（集团）有限公司（以下简称"山能装备"） 与兖矿能源均为山能集团控股子公司，此次交易构成关联交易。公开信息显示，这已经是近12个月内兖 矿能源与山能集团之间第五次关联交易。 《中国经营报》记者注意到，此次被收购的高端支架公司主营矿山装备。财务数据显示，2025年前三季 度，标的总资产和总负债均有所攀升，而净利润却呈下滑态势。 标的公司前三季度利润仅27万元 根据公告，兖矿能源拟通过全资附属公司兖矿东华重工有限公司（以下简称"东华重工"）收购山能装备 持有的高端支架公司100%股权，交易对价约3.45亿元。 兖矿能源方面在公告中解释称，高端支架公司与东华重工业务存在同业竞争关系，此次收购旨在解决该 问题，助力装备制造产业一体化与煤矿智能化建设，为煤矿安全高效开采与高质量 ...

转自：中国经营报 中经记者 陈婷 赵毅 深圳报道 一场作价6.8亿美元的并购，即将以"零现金"交易的形式展开…… 近日，心通医疗（2160.HK）正式公告收购微创心律管理有限公司（以下简称"心律管理"）100%股权， 对价为6.8亿美元（约合人民币48亿元），心通医疗通过向心律管理股东发行新股支付，即不涉及任何 现金交易。新股发行数量约39.54亿股，相当于心通医疗已发行股本约164%，价格为每股1.35港元。 这是一次关联交易。心通医疗、心律管理的控股股东均是微创医疗（0853.HK），且这两家公司目前均 处于亏损状态。其中，心通医疗在今年上半年亏损约人民币220万元，心律管理亏损4162万美元（约合 人民币近3亿元）。 此次交易的时间节点耐人寻味。4年前，微创医疗为心律管理引入投资机构，彼时约定若心律管理未能 在2025年7月17日前上市，或上市时市值少于15亿美元且募资额低于1.5亿美元，心律管理将面临赎回风 险。2023年5月，心律管理曾向港交所递交招股书谋求上市，但至今无果。就在上述约定心律管理上市 期限前1天，微创医疗宣布拟重组心律管理业务，将其与心通医疗合并。 此次并购是否为化解微创医疗对赌协议 ...

Core Points - The company is extending the commitment period to avoid competition until the end of 2030 due to certain assets not meeting the injection conditions within the original timeframe [10][20][16] - The board of directors has approved this extension, ensuring it aligns with regulatory guidelines and does not harm the interests of the company or its shareholders [21][22] Group 1: Company Overview - Jiangsu Lianyungang Port Co., Ltd. is involved in various port-related services, including cargo handling, warehousing, and logistics [6][4] - The company has a registered capital of 40,000 million RMB and is primarily owned by Sinopec and Jiangsu Lianyungang Port Group [2] Group 2: Financial Data - As of June 30, 2025, the company reported total assets of 501,313.26 million RMB and a net asset value of 78,442.47 million RMB, with a revenue of 304,054.29 million RMB and a net loss of 1,455.00 million RMB for the first half of 2025 [4] Group 3: Related Party Transactions - The company engages in daily transactions with related parties, including procurement of materials and services, which are conducted under fair pricing principles [7][9] - The company has signed agreements for land use rights and other services with its controlling shareholder, Lianyungang Port Group [8][9] Group 4: Commitment to Avoid Competition - The commitment to avoid competition was initially made in December 2020, and the extension is necessary due to the ongoing development of certain port assets [10][16] - The company has successfully injected some assets into its operations, but others still require improvement to meet the necessary conditions for injection [16][20] Group 5: Board Approval Process - The board of directors held meetings to discuss and approve the extension of the commitment, ensuring that all related parties recused themselves from voting [21][22]

Group 1 - The company held its second extraordinary general meeting of shareholders on December 5, 2025, with no resolutions being rejected [2][3] - The total number of shares with voting rights at the meeting was 746,174,300 shares after excluding shares held in the company's repurchase account [2] - The meeting was convened in accordance with the Company Law and the company's articles of association, with the chairman presiding over the meeting [3] Group 2 - The company approved several governance-related proposals, including the cancellation of the supervisory board and amendments to the articles of association [4][5] - All proposals related to the revision of governance systems and rules were passed unanimously [5][6] - The meeting was attended by all directors and supervisors, and the voting procedures were deemed valid [4][7] Group 3 - The company announced an expected related party transaction with Shengtong Intelligent Technology Co., Ltd., for a total amount not exceeding 16.5 million yuan for the year 2026 [11][12] - The transaction involves the provision of digital services and does not constitute a major asset reorganization [11] - The company had previously engaged in related transactions with Shengtong Intelligent amounting to 993.18 million yuan, which did not exceed 5% of the latest audited net assets [11][12] Group 4 - The company’s main business is non-clinical drug research services, and the collaboration with Shengtong Intelligent is expected to enhance operational efficiency and reduce costs [18] - The pricing for the services provided by Shengtong Intelligent will be based on a cost-plus model, ensuring alignment with market rates [16] - The independent directors and the board approved the related party transaction, confirming it aligns with the company's operational needs [19][20] Group 5 - The company plans to engage in daily related party transactions with Shuyitai Shen (Beijing) Biopharmaceutical Co., Ltd., which have been approved by the board [58][60] - These transactions are necessary for daily operations and are priced at market rates, ensuring no harm to the interests of the company or minority shareholders [65][66] - The company maintains its independence, with no reliance on these transactions for its main business or revenue [66] Group 6 - The company announced plans for entrusted financial management for 2026, with a maximum daily balance of 2 billion yuan for investments in low-risk financial products [69][72] - The purpose of the financial management is to enhance the efficiency of idle funds while ensuring the company's normal operations are not affected [71][78] - The board approved the financial management plan, which includes strict risk control measures [76][78] Group 7 - The company elected a new employee representative director, Li Ye, during the first meeting of the labor union committee on December 5, 2025 [79][80] - The new board will consist of 10 members, including 5 non-independent directors and 4 independent directors, complying with relevant regulations [79][80] - Li Ye has been with the company since 2007 and holds shares in the company, ensuring no conflicts of interest [80]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600726 900937 证券简称：华电能源 华电B股 公告编号：2025-041 华电能源股份有限公司 十一届二十一次董事会会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 华电能源股份有限公司（以下简称"公司"）于2025年11月28日以电子邮件和书面方式发出召开十一届二 十一次董事会的通知，会议于2025年12月5日在公司九楼会议室采用现场会议和视频相结合的方式召 开，公司董事9人，其中现场参会董事6人，董事郑钢先生、独立董事马雷先生以视频方式参会表决，董 事魏宁先生因工作安排无法出席本次会议，授权委托公司董事长郎国民先生代为行使表决权。公司董事 长郎国民主持会议，公司部分高级管理人员列席了会议，本次会议的召开符合《公司法》及《华电能源 股份有限公司章程》的有关规定，会议决议有效。会议审议通过了如下议案： 一、关于公司重大资产重组事项之标的资产业绩承诺期满减值测试情况的议案 本议案获同意票6票，反对票0票，弃权票0票。 关联董事李红淑、朱凤娥、郑钢 ...

Group 1 - The company plans to conduct deposit business with its affiliated bank, Hunan Sanxiang Bank, in 2026, with a daily deposit limit of up to RMB 6 billion [2][4][9] - The proposal will be submitted for shareholder meeting approval [3][15] - The transaction does not constitute a major asset restructuring as defined by relevant regulations [5] Group 2 - The affiliated bank, Hunan Sanxiang Bank, is 18% owned by the company's controlling shareholder, SANY Group, and its chairman is also a director of the bank [6] - The bank's total assets reached RMB 52.767 billion, with loans of RMB 32.18 billion and deposits of RMB 39.175 billion as of the end of 2024 [8] Group 3 - The deposit business will be conducted at market prices, ensuring fairness and transparency [11][12] - The independent directors have unanimously agreed that the transaction is fair and does not harm the interests of the company or minority shareholders [13][29] Group 4 - The company intends to provide financial assistance to its subsidiaries totaling up to RMB 7.15 billion, with a borrowing term of one year [19][21] - The financial assistance is aimed at meeting the operational funding needs of subsidiaries [23][29] Group 5 - The company expects to engage in daily related transactions in 2026, with procurement from related parties amounting to RMB 10.15765 billion and sales to related parties amounting to RMB 5.32732 billion [35][36] - The independent directors have confirmed that these transactions are necessary for production and will not affect the company's independence [33][34] Group 6 - The company plans to provide guarantees for its subsidiaries and independent third-party suppliers, with a total guarantee limit of RMB 1 billion for 2026 [59][60] - The company has not experienced any overdue guarantees as of October 31, 2025 [68]

拓荆科技公告，公司拟与关联方丰泉创投共同投资芯丰精密。公司拟以不超过人民币2.7亿元受让芯丰 精密原股东持有的998.38万元注册资本，占芯丰精密本轮融资后注册资本的比例为16.4154%；丰泉创投 拟以人民币3000万元受让芯丰精密原股东持有的110.93万元注册资本，占芯丰精密本轮融资后注册资本 的比例为1.8239%。本次交易涉及与关联方丰泉创投共同投资，构成关联交易，但不构成《上市公司重 大资产重组管理办法》规定的重大资产重组。本次交易事项已经公司第二届董事会第二十一次会议审议 通过，关联董事吕光泉先生和刘静女士已回避表决，本事项尚需提交公司股东会审议。 ...

格隆汇12月5日丨华电能源(600726.SH)公布，为优化公司资产结构、提升运营效率，公司控股子公司龙 电电气拟将其办公楼房产转让给依兰新能源。依据北京中企华资产评估有限责任公司所出具的资产评估 报告，评估基准日为2025年4月30日，龙电电气拟出售的资产评估价值为3,194.04万元(含增值税)。经与 依兰新能源协商一致，双方约定本次交易价格为3,194.04万元。依兰新能源的实际控制人为中国华电集 团有限公司，根据《上海证券交易所股票上市规则》的相关规定，本次交易构成关联交易。 ...